Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems.
To provide intraarterial chemotherapy of the liver in 30 outpatients with colorectal cancer metastases and other malignancies, 32 catheter-port systems were implanted percutaneously via the femoral artery. Mean patency was 229 days. Percutaneous placement was feasible and safe. Compared with surgical placement, the overall complication rate (12%) was comparable or less.
Herrmann
K A
KA
Institute of Clinical Radiology, Ludwig-Maximilians-University of Munich, Grosshadern Marchioninistr 15, D-81377 Munich, Germany. herrmann@ikra.med.uni-muenchen.de
Waggershauser
T
T
Sittek
H
H
Reiser
M F
MF
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002406:Catheterization, Peripheral / Q000009:adverse effects / Q000295:instrumentation; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000145:classification; D003110:Colonic Neoplasms / Q000473:pathology; D004867:Equipment Design; D005240:Feasibility Studies; D005260:Female; D005263:Femoral Artery; D005500:Follow-Up Studies; D006499:Hepatic Artery; D006801:Humans; D007269:Injections, Intra-Arterial / Q000009:adverse effects / Q000295:instrumentation; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000473:pathology; D013499:Surface Properties
D000970:Antineoplastic Agents